GET THE APP

Validation of RP-HPLC method for the quantification of NBromosuccinimide in Angiotensin II receptor antagonists in Pharmaceuticals | Abstract

Der Pharma Chemica
Journal for Medicinal Chemistry, Pharmaceutical Chemistry, Pharmaceutical Sciences and Computational Chemistry

ISSN: 0975-413X
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission Systemof respective journal.

Abstract

Validation of RP-HPLC method for the quantification of NBromosuccinimide in Angiotensin II receptor antagonists in Pharmaceuticals

Author(s): T.Kaleemullah*, Mansur Ahmed and Hemant Kumar Sharma

The present paper describes the development of a reversed-phase high performance liquid chromatographic (RP-HPLC) method for N-Bromosuccinimide (NBS) determination in group of “sartans” pharmaceuticals. The gradient LC method employs solution A and solution B as mobile phase. The solution A contains 0.01%v/v Ortho-phosphoric buffer and Acetonitrile as Solution B. Successful chromatographic separation were achieved on a Zorbax XDB C18, 250mm x 4.6mm, 5μm particle size column without co-elution of drugs and its process related impurities and degradation products. The developed RP-HPLC method was validated with respect to specificity, linearity, accuracy, precision and sensitivity with detection limits and quantification limits are 0.007 mg/ml and 0.022 mg/ml respectively [1]. To the best of our knowledge, a rapid LC method for the determination of NBS in pharmaceuticals, disclosed in this investigation was not published elsewhere.


PDF

Select your language of interest to view the total content in your interested language

30+ Million Readerbase
SCImago Journal & Country Rank
Google Scholar citation report
Citations : 25868

Der Pharma Chemica received 25868 citations as per Google Scholar report

Der Pharma Chemica peer review process verified at publons
Der Pharma Chemica- Journals on pharmaceutical chemistry